Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Business

>> AMGEN Latest News

NOV 21, 2014 - Zacks Investment Research

A Must Read - Share

Amgen and AbbVie Strengthen Manufacturing Facilities in Asia - Analyst Blog

Amgen (AMGN) announced the completion of its first next-generation biomanufacturing facility located in Singapore.

Tags: Amgen and AbbVie Strengthen Manufacturing Facilities in Asia - Analyst Blog,  Amgen Latest News

NOV 15, 2014 - TheStreet

A Must Read - Share

'Fast Money' Recap: Was Friday the Start of a Bull Rally in Gold?

NEW YORK (TheStreet) -- Gold has had trouble gaining upside traction in the past month, but the yellow metal jumped 2.3% on Friday. The Swiss National Bank may be forced to hold 20% of its assets in gold, a policy which is being voted for on Nov. 30.  This pending vote will likely put a "floor" in gold prices, Brian ...

Tags: 'Fast Money' Recap: Was Friday the Start of a Bull Rally in Gold?,  Amgen Latest News

NOV 13, 2014 - Zacks Investment Research

A Must Read - Share

NOV 12, 2014 - Bespoke Investment Group

A Must Read - Share

Best and Worst Performing S&P 500 Stocks on Earnings this Season

More than 400 of the S&P 500's companies have reported earnings since early October, and below is a list of the stocks that have reacted the most positively and negatively to their reports.  (For S&P 500 companies that report in the morning, we use that day's change.  For companies that report after the close, we use the next day's change.) ...

Tags: Best and Worst Performing S&P 500 Stocks on Earnings this Season,  Amgen Latest News

NOV 12, 2014 - Benzinga

A Must Read - Share

UPDATE: Deutsche Bank Reiterates On Amgen On Potential Of New Drugs

In a report published Wednesday, Deutsche Bank analyst Robyn Karnauskas reiterated a Buy rating on Amgen (NASDAQ: AMGN), and raised the price target from $190.00 to $192.00. Latest Ratings for AMGN DateFirmActionFromTo Oct 2014CitigroupMaintainsBuy Oct 2014Credit SuisseMaintainsNeutral Oct 2014NomuraUpgradesNeutralBuy View More Analyst Ratings for AMGN View the Latest Analyst Ratings

Tags: UPDATE: Deutsche Bank Reiterates On Amgen On Potential Of New Drugs,  Amgen Latest News